USANA HEALTH SCIENCES, INC. Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31)
USANA HEALTH SCIENCES, INC. (USNA) reported Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31) of $3.10 million for the 3-month period ending 2014-09-27, per its 10-Q filed 2014-11-06.
Discontinued › Income Statement › Other Income
us-gaap:DeferredRevenueRevenueRecognized · last filed 2014-11-06
- USANA HEALTH SCIENCES, INC. deferred revenue, revenue recognized (deprecated 2016-01-31) for the quarter ending 2014-09-27 was $3.10M.
| Period end | Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31) 3 month |
|---|---|
| 2014-09-27 | $3.10M 10-Q · filed 2014-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |